N-(5-BROMOPYRAZIN-2-YL)-2,2-DIMETHYLPROPANAMIDE, 95.0%, 1g

3-Formyl-1H-indazole-5-carboxylic acid, 95.0%, 1g

ethyl 5-formyl-3-nitro-1H-pyrrole-2-carboxylate, 95%, 100mg

n-(2-Amino-4-bromophenyl)acetamide, 97%, 250mg

5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one, 98%, 25mg

2-(Adamantan-1-yl)ethan-1-amine hydrochloride, 97%, 250mg

Recipiente de reacción con brida plana cilíndrico, graduado (1) Fondo redondo, DN 100, 105 mm, Altura, 205 mm, 1 Pieza

Ethyl 4-(2-aminoethyl)benzoate hydrochloride, 98%, 250mg

2-Aminomethyl-benzooxazole, 97.0%, 1g

2,5-Dichloroquinoline, 95.0%, 1g

[1,1′-Binaphthalene]-2-carboxylic acid,2′-[(diethylamino)carbonyl]-,(S)-, 100mg

Dimethyl octadecanedioate, 96%, 25g

Ethyl 4-(1-trityl-1H-imidazol-4-yl)butanoate, 97%, 1g